A commonly occurring polymorphism upstream of the estrogen receptor alpha alters transcription and is associated with increased HDL

Atherosclerosis

Volumn 199, Issue 2, 2008, Pages 354-361

  Figtree, Gemma A ^a,b   Grieve, Stuart M ^b   Speller, Bridget ^b   Geiger, Mary Jane ^c   Robinson, Bruce G ^b   Channon, Keith M ^b   Ragoussis, Jiannis ^a   Collins, Peter ^d   Watkins, Hugh ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ELI LILLY AND COMPANY   (United States)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Estrogen receptor; Genetics; HDL cholesterol; Hormone; Polymorphism

Indexed keywords

CHOLESTEROL; ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BINDING SITE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; ETHNICITY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; ALLELES; CHOLESTEROL, HDL; DIABETES MELLITUS; DNA; ESTROGEN RECEPTOR ALPHA; FEMALE; GENOTYPE; HUMANS; LIPOPROTEINS, HDL; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION, GENETIC;

EID: 47649100439     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.02.012     Document Type: Article

References (30)

1. Watts G.F., Mandalia S., Brunt J.N., Slavin B.M., Coltart D.J., and Lewis B. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism 42 (1993) 1461-1467
2. Syvanne M., Nieminen M.S., Frick M., et al. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol. Circulation 98 (1998) 1993-1999
3. Gordon D.J., Probstfield J.L., Garrison R.J., et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 79 (1989) 8-15
4. Bush T.L., Barrett-Connor E., Cowan L.D., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75 (1987) 1102-1109
5. Knopp R.H., Zhu X., and Bonet B. Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis 110 Suppl. 91 (1994)
6. Li Z., McNamara J.R., Fruchart J.C., et al. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res 37 (1996) 1886-1896
7. Lamon-Fava S., Ordovas J.M., and Schaefer E.J. Estrogen increases apolipoprotein (apo) A-I secretion in hep G2 cells by modulating transcription of the apo A-I gene promoter. Arterioscler Thromb Vasc Biol 19 (1999) 2960-2965
8. Hodgin J.B., Krege J.H., Reddick R.L., Korach K.S., Smithies O., and Maeda N. Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice. J Clin Invest 107 (2001) 333-340
9. Mahaney M.C., Blangero J., Rainwater D.L., et al. A major locus influencing plasma high-density lipoprotein cholesterol levels in the San Antonio Family Heart Study. Segregation and linkage analyses. Arterioscler Thromb Vasc Biol 15 (1995) 1730-1739
10. Peacock J.M., Arnett D.K., Atwood L.D., et al. Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol: The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 21 (2001) 1823-1828
11. Yang Q., Lai C.Q., Parnell L., et al. Genome-wide linkage analyses and candidate gene fine mapping for HDL3 cholesterol: the Framingham Study. J Lipid Res 46 (2005) 1416-1425
12. Matsubara Y., Murata M., Kawano K., et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 17 (1997) 3006-3012
13. Kikuchi T., Hashimoto N., Kawasaki T., and Uchiyama M. Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children. Acta Paediatr 89 (2000) 42-45
14. Sowers M.R., Symons J.P., Jannausch M.L., Chu J., and Kardia S.R. Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women's Health Across the Nation (SWAN). Am J Med 119 (2006) S61-S68
15. Herrington D.M., Howard T.D., Hawkins G.A., et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 346 (2002) 967-974
16. Schubert E.L., Lee M.K., Newman B., and King M.C. Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility. J Steroid Biochem Mol Biol 71 (1999) 21-27
17. Penolazzi L., Lambertini E., Aguiari G., del Senno L., and Piva R. Cis element 'decoy' against the upstream promoter of the human estrogen receptor gene. Biochim Biophys Acta 1492 (2000) 560-567
18. Underhill P.A., Jin L., Zemans R., Oefner P.J., and Cavalli-Sforza L.L. A pre-Columbian Y chromosome-specific transition and its implications for human evolutionary history. Proc Natl Acad Sci USA 93 (1996) 196-200
19. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 (1996) 1516-1517
20. Boffa M.B., Hamill J.D., Maret D., et al. Acute phase mediators modulate thrombin-activable fibrinolysis inhibitor (TAFI) gene expression in HepG2 Cells. J Biol Chem 278 (2003) 9250-9257
21. Barrett-Connor E., Mosca L., Collins P., et al. The Raloxifene use for the heart trial I. Effects of Raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355 (2006) 125-137
22. Lancaster A., Nelson M.P., Single R.M., Meyer D., and Thomson G. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. Pacific Symp Biocomput (2003) 514-525
23. Wingender E., Chen X., Fricke E., et al. The TRANSFAC system on gene expression regulation. Nucleic Acids Res 29 (2001) 281-283
24. Saponaro S., Guarnieri V., Pescarmona G.P., and Silvagno F. Long-term exposure to dehydroepiandrosterone affects the transcriptional activity of the glucocorticoid receptor. J Steroid Biochem Mol Biol 103 (2007) 129-136
25. Mosca L., Barrett-Connor E., Wenger N.K., et al. Design and methods of the Raloxifene Use for The Heart (RUTH) Study. Am J Cardiol 88 (2001) 392-395
26. Herrington D.M., Howard T.D., Brosnihan K.B., et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105 (2002) 1879-1882
27. Stavreus-Evers A., Parini P., Freyschuss B., et al. Estrogenic influence on the regulation of hepatic estrogen receptor-alpha and serum level of angiotensinogen in female rats. J Steroid Biochem Mol Biol 78 (2001) 83-88
28. Freyschuss B., Sahlin L., Masironi B., and Eriksson H. The hormonal regulation of the oestrogen receptor in rat liver: an interplay involving growth hormone, thyroid hormones and glucocorticoids. J Endocrinol 142 (1994) 285-298
29. Schuit S.C.E., Oei H.-H.S., Witteman J.C.M., et al. Estrogen receptor {alpha} gene polymorphisms and risk of myocardial infarction. JAMA 291 (2004) 2969-2977
30. Shearman A.M., Cooper J.A., Kotwinski P.J., et al. Estrogen receptor {alpha} gene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circ Res 98 (2006) 590-592